Wolverine Asset Management’s TriSalus Life Sciences TLSI Stock Holding History

Wolverine Asset Management’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.69K	Buy	810 +464	+134%	+$1.84K	﹤0.01%	1504
2026 Q1	$1.38K	Buy	+346	New	+$1.69K	﹤0.01%	1586
2025 Q4	–	Sell	-820	Closed	-$3.81K	–	1869
2025 Q3	$3.81K	Buy	820 +194	+31%	+$908	﹤0.01%	1451
2025 Q2	$3.41K	Buy	+626	New	+$3.36K	﹤0.01%	1451
2025 Q1	–	Sell	-1,032	Closed	-$5.17K	–	1775
2024 Q4	$5.17K	Sell	1,032 -3,716	-78%	-$15.7K	﹤0.01%	1415
2024 Q3	$21.9K	Sell	4,748 -38,732	-89%	-$205K	﹤0.01%	1263
2024 Q2	$240K	Buy	+43,480	New	+$369K	﹤0.01%	966
2023 Q4	–	Sell	-415	Closed	-$2.12K	–	1997
2023 Q3	$2.12K	Buy	+415	New	+$3.4K	﹤0.01%	1644

Other funds holding TLSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wolverine Asset Management's TLSI Position: Q2 2026 in Review

Wolverine Asset Management increased its TriSalus Life Sciences (TLSI) stake by 134% in Q2 2026, buying an estimated $1.84K and bringing the position to 810 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #1504.

Wolverine Asset Management first reported a position in TLSI in Q3 2023 and has held it in 8 quarters since. The position peaked at $240K in Q2 2024. 38 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

Wolverine Asset Management held 810 shares of TriSalus Life Sciences worth $3.69K as of Q2 2026.
Wolverine Asset Management bought 464 TriSalus Life Sciences shares in Q2 2026, an estimated $1.84K.
TriSalus Life Sciences made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1504 holding.
Wolverine Asset Management first reported a position in TriSalus Life Sciences in Q3 2023 and has held it in 8 quarters since.
Wolverine Asset Management's TriSalus Life Sciences position peaked at $240K in Q2 2024.
38 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.